DK524187D0 - Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder - Google Patents

Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder

Info

Publication number
DK524187D0
DK524187D0 DK524187A DK524187A DK524187D0 DK 524187 D0 DK524187 D0 DK 524187D0 DK 524187 A DK524187 A DK 524187A DK 524187 A DK524187 A DK 524187A DK 524187 D0 DK524187 D0 DK 524187D0
Authority
DK
Denmark
Prior art keywords
amino acid
delivery
mammal
websites
ligand
Prior art date
Application number
DK524187A
Other languages
Danish (da)
English (en)
Other versions
DK524187A (da
Inventor
Harvey H Ashmead
Dewayne H Ashmead
Darrell J Graff
Original Assignee
Albion Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albion Lab filed Critical Albion Lab
Publication of DK524187A publication Critical patent/DK524187A/da
Publication of DK524187D0 publication Critical patent/DK524187D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK524187A 1986-02-06 1987-10-06 Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder DK524187D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/826,786 US4863898A (en) 1986-02-06 1986-02-06 Amino acid chelated compositions for delivery to specific biological tissue sites
PCT/US1987/000310 WO1987004622A1 (fr) 1986-02-06 1987-02-04 Compositions chelatees d'acides amines se fixant dans des sites specifiques de tissus biologiques

Publications (2)

Publication Number Publication Date
DK524187A DK524187A (da) 1987-10-06
DK524187D0 true DK524187D0 (da) 1987-10-06

Family

ID=25247529

Family Applications (1)

Application Number Title Priority Date Filing Date
DK524187A DK524187D0 (da) 1986-02-06 1987-10-06 Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder

Country Status (10)

Country Link
US (1) US4863898A (fr)
EP (1) EP0262178B1 (fr)
JP (1) JP2583434B2 (fr)
KR (1) KR880700668A (fr)
AT (1) ATE93142T1 (fr)
AU (1) AU599637B2 (fr)
CA (1) CA1293444C (fr)
DE (1) DE3787061T2 (fr)
DK (1) DK524187D0 (fr)
WO (1) WO1987004622A1 (fr)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5070080A (en) * 1988-08-10 1991-12-03 Fahim Mostafa S Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form
US6451341B1 (en) 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
WO1993010777A1 (fr) * 1991-11-25 1993-06-10 Albion International, Inc. Composition et methode permettant de reduire les contraintes d'oxydation cellulaire par radicaux libres chez les animaux homeothermes
US5882685A (en) * 1992-01-22 1999-03-16 Albion Laboratories, Inc. Food energy utilization from carbohydrates in animals
TW233264B (fr) 1992-02-03 1994-11-01 Otsuka Pharma Co Ltd
US5270297A (en) * 1992-07-23 1993-12-14 Metagenics, Inc. Endurance and rehydration composition
US5661103A (en) * 1992-11-05 1997-08-26 Donlar Corporation Seed treatment composition and method
US5783523A (en) * 1992-11-05 1998-07-21 Donlar Corporation Method and composition for enhanced hydroponic plant productivity with polyamino acids
US5580840A (en) * 1992-11-05 1996-12-03 Donlar Corporation Method and composition for preservation of cut flowers
US5350735A (en) * 1992-11-05 1994-09-27 Donlar Corporation Composition and method for enhanced fertilizer uptake by plants
US5814582A (en) * 1992-11-05 1998-09-29 Donlar Corporation Method for enhanced plant productivity
US5854177A (en) * 1992-11-05 1998-12-29 Donlar Corporation Method for enhanced hydroponic plant productivity with polymeric acids
WO1994015482A1 (fr) * 1992-12-31 1994-07-21 Albion International, Inc. Optimisation de l'utilisation de proteines a l'aide de chelates d'acides amines
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
US5389360A (en) * 1993-05-13 1995-02-14 The Procter & Gamble Company Oral compositions
US5496539A (en) * 1993-07-22 1996-03-05 The Procter & Gamble Company Oral compositions
US5534542A (en) * 1994-01-24 1996-07-09 Northwestern University Methods and materials relating to a bi-metallic cross-linking species
GB9416767D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
WO1996005867A2 (fr) * 1994-08-18 1996-02-29 Nycomed Imaging A/S Compositions
US5863519A (en) * 1994-08-18 1999-01-26 Nycomed Imaging As Composition and method of MRI using both a positive and a negative contrast agent
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
WO1996008232A1 (fr) * 1994-09-15 1996-03-21 The Procter & Gamble Company Compositions bucco-dentaires
US5565199A (en) * 1995-02-07 1996-10-15 Page; Elliot W. Systems and methods for the synthesis of natural base steroidal hormones and more especially estrogens and progesterone and estrogen-like and progesterone-like compounds and their derivatives derived as phytohormones from herbaceous plants
US5891418A (en) * 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
AU6482596A (en) 1995-07-03 1997-02-05 Wilson T. Crandall Transdermal and oral treatment of androgenic alopecia
DK81095A (da) * 1995-07-11 1997-01-12 Henrik S Thomsen Peroralt MR-kontraststof til lever og øvre tarmkanal
US5670344A (en) * 1996-02-02 1997-09-23 The Procter & Gamble Company Preventing undesired color formation in iron fortified chocolate-flavored beverages by including edible acids or their salts
GB2311543A (en) * 1996-03-29 1997-10-01 Procter & Gamble Tripeptide builder for bleaching and detergent compositions
US6331285B1 (en) 1996-06-05 2001-12-18 Palatin Technologies, Inc. Structurally determined cyclic metallo-constructs and applications
US5707670A (en) * 1996-08-29 1998-01-13 The Procter & Gamble Company Use of bilayer forming emulsifiers in nutritional compositions comprising divalent mineral salts to minimize off-tastes and interactions with other dietary components
WO1998018491A1 (fr) * 1996-10-28 1998-05-07 BURGSTINER, Jacqueline, Cook Procedes et compositions pour la complementation alimentaire
GB9622659D0 (en) * 1996-10-31 1997-01-08 Unilever Plc Hair treatment composition
US5888553A (en) * 1997-04-08 1999-03-30 Infinity, Inc. Non-steroidal anabolic composition
US5935909A (en) * 1997-09-16 1999-08-10 Donlar Corporation Treatment of tree seedlings to enhance survival rate
US6197815B1 (en) 1998-03-18 2001-03-06 J.H. Biotech, Inc. Amino acid chelates to reduce still births and increase birth weight in non-human animals
US6423519B1 (en) * 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
US7153503B1 (en) 1998-12-19 2006-12-26 Janeel Henderson Comprehensive dietary supplement
GB2362104B (en) * 1998-12-19 2004-03-31 Today Inc 4 Comprehensive dietary supplements
US6159530A (en) * 1999-06-18 2000-12-12 Albion International, Inc. Cereal grains fortified with amino acid chelates and process of making
US6207204B1 (en) 1999-06-18 2001-03-27 Albion International, Inc. Cereal grain kernels fortified with amino acid chelates and method of making
US6114379A (en) * 1999-07-07 2000-09-05 Albion Laboratories, Inc. Bioavailable chelates of creatine and essential metals
US6689383B1 (en) * 1999-10-08 2004-02-10 The United States Of America As Represented By The Secretary Of Agriculture Chromium-histidine complexes as nutrient supplements
US6294207B1 (en) 1999-11-01 2001-09-25 Albion International, Inc. Calcium fortification of oleaginous foods
US6299914B1 (en) 1999-11-01 2001-10-09 Albion International, Inc. Compositions and methods for calcium fortification of dairy products and oleaginous foods
BR0107933A (pt) 2000-01-28 2004-01-06 Procter & Gamble Compostos de arginina saborosos e seus usos para saúde cardiovascular
US6166071A (en) * 2000-03-13 2000-12-26 Albion International, Inc. Zinc amino acid chelates having ligands comprised of glycine and a sulfur-containing amino acids
US6358541B1 (en) 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
KR100421466B1 (ko) * 2000-07-11 2004-03-10 지성규 체내에 흡수되기 용이한 아연-올리고펩티드의 제조방법
US6352714B1 (en) 2000-07-11 2002-03-05 Der, Inc. Method of producing a metal nutrient for an animal feed
US6426424B1 (en) 2000-10-11 2002-07-30 Albion International, Inc. Composition and method for preparing granular amino acid chelates and complexes
US6518240B1 (en) 2000-10-11 2003-02-11 Albion International, Inc. Composition and method for preparing amino acid chelates and complexes
US6710079B1 (en) 2000-10-11 2004-03-23 Albion International, Inc. Composition and method for preparing amino acid chelates and complexes free of interfering complex ions
US6458981B1 (en) 2000-10-11 2002-10-01 Albion International, Inc. Composition and method for preparing amino acid chelate hydroxides free of interfering ions
US7385025B2 (en) 2000-12-19 2008-06-10 Palatin Technologies, Inc. Metallopeptide compounds
JP2003040784A (ja) * 2001-01-31 2003-02-13 Japan Science & Technology Corp 血糖降下剤
US6864242B2 (en) 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
US7090878B2 (en) 2001-05-31 2006-08-15 The Procter & Gamble Company Mineral fortified water
US20030049352A1 (en) * 2001-05-31 2003-03-13 Haile Mehansho Fortified drinking water
US6716814B2 (en) 2001-08-16 2004-04-06 Albion International, Inc. Enhancing solubility of iron amino acid chelates and iron proteinates
US7560123B2 (en) * 2004-08-12 2009-07-14 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US7910137B2 (en) * 2001-11-28 2011-03-22 Albion International, Inc. Metal carnitine chelates
US20060013892A1 (en) * 2001-11-28 2006-01-19 Albion International Inc. Administration of amino acid chelates for reduction in alcohol dependency
US20030158171A1 (en) * 2001-11-28 2003-08-21 Albion International, Inc. Chelates and complexes for reduction in alcohol dependency
US20030203097A1 (en) * 2002-04-24 2003-10-30 The Procter & Gamble Company Acidic compositions comprising protein and fiber and processes of their preparation
US7393552B2 (en) * 2002-04-24 2008-07-01 The Procter & Gamble Company Compositions comprising protein and fatty acid
US20030203042A1 (en) * 2002-04-24 2003-10-30 Cook Lisa Ann Compositions comprising milk protein concentrate and fatty acid and processes of their preparation
US7994217B2 (en) * 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
US7279187B2 (en) * 2003-02-14 2007-10-09 The Procter & Gamble Company Mineral fortification systems
US20030045473A1 (en) * 2002-07-19 2003-03-06 Sarama Robert Joseph Compositions, kits, and methods for cardiovascular health
WO2004050664A1 (fr) * 2002-12-05 2004-06-17 Md Bioalpha Co., Ltd. Procede pour la preparation de chelate d'acide amine
US8617617B2 (en) * 2002-12-10 2013-12-31 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
US6814983B2 (en) * 2002-12-10 2004-11-09 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US7455857B2 (en) * 2003-04-08 2008-11-25 Janeel Henderson Energy generating composition
US7968125B2 (en) * 2003-04-08 2011-06-28 Janeel Henderson Energy generating composition
US7371422B2 (en) * 2003-05-13 2008-05-13 The Procter & Gamble Company Cereal grain kernels fortified with iron and calcium
SE527491C2 (sv) * 2003-12-19 2006-03-21 Cmc Contrast Ab Kontraktsmedelskomposition för magnetisk resonanstomografi för oral administration
US20050239763A1 (en) * 2004-04-21 2005-10-27 Albion International, Inc. Non-GMO metal amino acid chelates and non-GMO metal amino acid chelate-containing compositions
US20050235718A1 (en) * 2004-04-21 2005-10-27 Kevin Dickinson Organic amino acid chelates, methods for making such chelates, and methods for using such chelates
US7838042B2 (en) * 2004-04-21 2010-11-23 Albion International, Inc. Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions
US8101587B2 (en) 2004-08-12 2012-01-24 Everett Laboratories, Inc. Kits for nutrition supplementation
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
US20060178834A1 (en) * 2005-02-08 2006-08-10 Brewer Deanna M Systems and methods for optimizing crop yield with amino acid chelates and complexes
EP1922372A4 (fr) * 2005-09-06 2010-11-10 Novus Int Inc Compositions de peinture marine antisalissure
CA2625661A1 (fr) * 2005-10-12 2007-04-19 Trojanon Gmbh & Co. Kg Composition pharmaceutique synergique
JP4975751B2 (ja) * 2005-10-13 2012-07-11 グ、ジェニファー、エル． ミネラル・コラーゲン・キレートおよびその製造方法と使用方法
EP1993607A4 (fr) * 2006-01-10 2012-03-28 Pipex Inc Compositions pharmaceutiques et méthodes permettant d'obtenir et de maintenir un taux de cuivre cible, stable, et de prévenir et de traiter des maladies du système nerveux central liées au taux de cuivre sérique
US8007846B2 (en) 2006-01-18 2011-08-30 Albion International, Inc. Mixed amino acid/mineral compounds having improved solubility
US20110098177A1 (en) * 2006-03-28 2011-04-28 Novus International Inc. Methods and compositions of plant micronutrients
US20070270591A1 (en) * 2006-05-16 2007-11-22 Ashmead H Dewayne Iron (II) amino acid chelates with reducing agents attached thereto
US20070269495A1 (en) * 2006-05-18 2007-11-22 Ashmead H Dewayne Compositions and methods for enhancing mineral levels in animals with reduced environmental impact
KR100927958B1 (ko) * 2006-07-13 2009-11-24 주식회사 머젠스 금속의 흡수를 촉진시키는 금속-산성아미노산 킬레이트를함유하는 조성물
US20080194679A1 (en) * 2007-02-14 2008-08-14 Ashmead H Dewayne Compositions and methods for increasing metabolic activity in animal tissue
US20080194407A1 (en) * 2007-02-14 2008-08-14 Ashmead H Dewayne High nitrogen containing chelate compositions suitable for plant delivery
WO2008105983A1 (fr) * 2007-02-27 2008-09-04 Albion International, Inc. Absorption de minéraux par l'estomac
WO2009089493A2 (fr) * 2008-01-11 2009-07-16 Albion International, Inc. Chélates d'acide aminé et de nitrate
WO2009140408A2 (fr) * 2008-05-13 2009-11-19 University Of Kansas Marqueur se présentant sous la forme d'un peptide map (metal abstraction peptide) et procédés associés
BRPI0915508B1 (pt) * 2008-07-09 2019-11-19 Melaleuca Inc complexo de polissacarídeos de mineral-aminoácido, processo para preparar o referido complexo, e composição compreendendo dois ou mais dos referidos compostos
GB2468675B (en) * 2009-03-17 2012-01-11 Calinnova Ltd A horse calming composition comprising a calcium coordinated compound
PL217815B1 (pl) * 2009-12-14 2014-08-29 Olimp Lab Spółka Z Ograniczoną Odpowiedzialnością Napój izotoniczny z chelatami
US8741375B2 (en) 2011-06-07 2014-06-03 Zinpro Corporation Mixed amino acid metal salt complexes
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
CN103781471B (zh) 2011-09-08 2019-02-12 健康科学西部大学 癌症治疗中的靶向脂质体
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
WO2013181461A2 (fr) 2012-06-01 2013-12-05 University Of Kansas Peptide de capture de métal avec une activité superoxyde dismutase
HUP1200394A2 (en) * 2012-06-29 2014-02-28 Bata Zrt Dr Bactericidal effect of metal chelate
US8968807B1 (en) 2013-09-24 2015-03-03 Zinpro Corporation Use of ethylene diamine metal complexes to deliver highly absorbable metals for animal nutrition
WO2015195491A1 (fr) * 2014-06-18 2015-12-23 Thetis Pharmaceuticals Llc Complexes d'acides aminés minéraux d'agents actifs
US11844810B2 (en) 2015-08-14 2023-12-19 Scott Lowell Crain Enhancement of vaccine efficacy and antibiotic efficacy
EP3454907B1 (fr) 2016-06-03 2020-07-22 Thetis Pharmaceuticals LLC Compositions et méthodes en lien avec des sels de médiateurs
KR20190062142A (ko) 2017-11-28 2019-06-05 (주)비티엔 면역 증강 활성을 가지는 아미노산 미네랄 복합체 및 이를 포함하는 식품, 약학 또는 사료용 조성물
EP3720415A4 (fr) * 2017-12-06 2021-11-24 Steven W. Bailey Compositions peptidiques pour ralentir la dégradation de compléments de vitamines et de minéraux, d'aliments, de produits pharmaceutiques et cosmétiques
KR102322269B1 (ko) * 2019-06-28 2021-11-05 주식회사 리앤씨바이오 Ca-콜라겐 펩타이드의 킬레이트 복합체 및 그 제조 방법
US12036286B2 (en) 2021-03-18 2024-07-16 Seagen Inc. Selective drug release from internalized conjugates of biologically active compounds
KR102286032B1 (ko) * 2021-03-26 2021-08-11 농업회사법인 완주수정바이오 주식회사 오메가 3 및 기능성 지방산이 강화된 육류 생산을 위한 가축용 사료 첨가제
CN114010618B (zh) * 2021-11-16 2023-10-27 吉林大学 一种在水溶液中制备的铁/寡肽复合物包覆的羟基氧化铁纳米梭及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887704A (en) * 1974-03-12 1975-06-03 Joseph Lichtenstein Aqueous zinc solutions for physiological use
US4167564A (en) * 1974-09-23 1979-09-11 Albion Laboratories, Inc. Biological assimilation of metals
US4020158A (en) * 1975-08-08 1977-04-26 Ashmead H H Increasing metals in biological tissue
US4183947A (en) * 1977-01-13 1980-01-15 Cockerill Vernon Nutritional and therapeutic iron composition and method of making
US4172072A (en) * 1977-10-20 1979-10-23 Ashmead H H Buffered enzymatically produced metal proteinates
CA1139229A (fr) * 1979-06-20 1983-01-11 Thomas W. Ritchey Sel de zinc avec de la glycine pour compositions orales
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4599152A (en) * 1985-05-24 1986-07-08 Albion Laboratories Pure amino acid chelates

Also Published As

Publication number Publication date
DE3787061T2 (de) 1993-12-09
CA1293444C (fr) 1991-12-24
WO1987004622A1 (fr) 1987-08-13
KR880700668A (ko) 1988-04-11
AU7038587A (en) 1987-08-25
AU599637B2 (en) 1990-07-26
DK524187A (da) 1987-10-06
ATE93142T1 (de) 1993-09-15
EP0262178A1 (fr) 1988-04-06
EP0262178A4 (fr) 1989-10-12
JP2583434B2 (ja) 1997-02-19
US4863898A (en) 1989-09-05
JPS63502749A (ja) 1988-10-13
EP0262178B1 (fr) 1993-08-18
DE3787061D1 (de) 1993-09-23

Similar Documents

Publication Publication Date Title
DK524187A (da) Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder
ES2173400T3 (es) Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido.
PL300194A1 (en) Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
MX172918B (es) Composicion a base de l-3,4-dihidroxifenilalanina
JO1883B1 (en) Enrofloxacin injection or infusion solutions
TR200100273T2 (tr) Enjeksiyon için parasetamol bazlı farmasötik bileşim.
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
EP0228192A3 (fr) Oligopeptides-inhibiteurs de la rénine, leur préparation et leur utilisation
EP0273800A3 (en) Hirudine variants, their use and preparation
DE3579471D1 (de) Orales dextran enthaltende zusammensetzungen.
AU8230187A (en) N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
ATE59295T1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
NO883520L (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
SE8107611L (sv) Oral komposition
DE69631169D1 (de) Herstellung von (s)-decahydroisochinolin-3-carbonsäure-t-butylamid
DK0404750T3 (da) Vævsinhibitor for metalloproteaser
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DE69834929D1 (de) Verwendung eines organspezifischen ernährungmittels
ATE26109T1 (de) Acetylcystein-salze, ihre herstellung und verwendung.
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
KR930012023A (ko) 환원된 형태의 비글리코실화 재조합 인체 il2의 안정화된 제약 조성물 및 그의 제조방법
EP0063328A3 (fr) Compositions contenant la sécrétine et procédé pour prévenir l'adsorption de la sécrétine
NO910933D0 (no) Nytt pentapeptid og fremgangsmaate for fremstilling derav.
ES8608861A1 (es) Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales de fosfomicina.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment